![Gervais Tougas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gervais Tougas
Directeur/Membre du Conseil chez
Novartis Europharm Ltd.
Profil
Gervais Tougas is currently working as a Director at Novartis Europharm Ltd. He previously worked as the Chief Medical Officer & Head-Patient Safety at Novartis AG and as the Chief Medical Officer at Maat Pharma SA from 2023 to 2024.
Postes actifs de Gervais Tougas
| Sociétés | Poste | Début |
|---|---|---|
Novartis Europharm Ltd.
 Novartis Europharm Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Directeur/Membre du Conseil | 09/01/2014 |
Anciens postes connus de Gervais Tougas
| Sociétés | Poste | Fin |
|---|---|---|
| MAAT PHARMA | Directeur Technique/Scientifique/R&D | 24/06/2024 |
| NOVARTIS AG | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Maat Pharma SA
 Maat Pharma SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops and commercializes patient-microbiome symbiosis to improve survival outcomes in oncology | Health Technology |
Novartis Europharm Ltd.
Novartis Europharm Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
